CYCLOOXYGENASE -2 AND CANCER: A silent link with fatal ending
Keywords:
COX-2 Cyclooxygenase 2.Abstract
Abstract: Remarkable evolutions in pathogenic role of Cyclooxygenase-2 (COX-2) in tumorigenesis have diverted
the cancer research in the direction of COX-2 inhibitors. An expanding body of evidence indicates that down
regulation of cyclooxygenase 2 will be an important strategy for preventing cancer because COX-2 catalyzes the
formation of prostaglandins(PGs) and these prostaglandins have multiple effects that favor tumorigenesis. It is
proved that during the process of chronic inflammation several cytokines and inflammatory mediators are released
which act during the different stages of carcinogenesis. Among all these mediators COX 2 are the key player. COX2
is found to be over expressed in several malignancies like colorectal carcinoma, squamous cell carcinomas of head
and neck, carcinomas of urinary bladder, liver, stomach, breast as well as hematological malignancies. Our review
article aims to summarize the role of COX 2 in various cancers and the mechanisms responsible for carcinogenesis.
The informations gathered in this review are taken mainly from articles published in different international
journals.
Downloads
Published
Issue
Section
License
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
